Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals.

Exosomes are small vesicles ranging in size from 30 nm to 100 nm that are released both constitutively and upon stimulation from a variety of cell types. They are found in a number of biological fluids and are known to carry a variety of proteins, lipids, and nucleic acid molecules. Originally thought to be little more than reservoirs for cellular debris, the roles of exosomes regulating biological processes and in diseases are increasingly appreciated. Several methods have been described for isolating exosomes from cellular culture media and biological fluids. Due to their small size and low density, differential ultracentrifugation and/or ultrafiltration are the most commonly used techniques for exosome isolation. However, plasma of HIV-1 infected individuals contains both exosomes and HIV viral particles, which are similar in size and density. Thus, efficient separation of exosomes from HIV viral particles in human plasma has been a challenge. To address this limitation, we developed a procedure modified from Cantin et. al., 2008 for purification of exosomes from HIV particles in human plasma. Iodixanol velocity gradients were used to separate exosomes from HIV-1 particles in the plasma of HIV-1 positive individuals. Virus particles were identified by p24 ELISA. Exosomes were identified on the basis of exosome markers acetylcholinesterase (AChE), and the CD9, CD63, and CD45 antigens. Our gradient procedure yielded exosome preparations free of virus particles. The efficient purification of exosomes from human plasma enabled us to examine the content of plasma-derived exosomes and to investigate their immune modulatory potential and other biological functions.

[1]  V. Bond,et al.  Association of Cytokines With Exosomes in the Plasma of HIV-1-Seropositive Individuals. , 2015, The Journal of infectious diseases.

[2]  J. DiStefano,et al.  A modified precipitation method to isolate urinary exosomes. , 2015, Journal of visualized experiments : JoVE.

[3]  Andrew F. Hill,et al.  Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles , 2014, Journal of extracellular vesicles.

[4]  Seena K. Ajit,et al.  Purification and microRNA profiling of exosomes derived from blood and culture media. , 2013, Journal of visualized experiments : JoVE.

[5]  Lynne T. Bemis,et al.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.

[6]  S. Okada,et al.  HIV-1 Proteins Preferentially Activate Anti-Inflammatory M2-Type Macrophages , 2012, The Journal of Immunology.

[7]  J. Lötvall,et al.  Isolation and Characterization of RNA-Containing Exosomes , 2012, Journal of visualized experiments : JoVE.

[8]  N. Raab-Traub,et al.  Microvesicles and Viral Infection , 2011, Journal of Virology.

[9]  V. Bond,et al.  HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals. , 2011, AIDS research and human retroviruses.

[10]  C. Williamson,et al.  Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression , 2010, AIDS.

[11]  G. Cagney,et al.  HIV Nef is Secreted in Exosomes and Triggers Apoptosis in Bystander CD4+ T Cells , 2010, Traffic.

[12]  V. Vullo,et al.  Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells. , 2009, Cell host & microbe.

[13]  Mario Roederer,et al.  Emerging concepts in the immunopathogenesis of AIDS. , 2009, Annual review of medicine.

[14]  C. Gilbert,et al.  Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. , 2008, Journal of immunological methods.

[15]  J. Altman,et al.  IL-15 Treatment during Acute Simian Immunodeficiency Virus (SIV) Infection Increases Viral Set Point and Accelerates Disease Progression despite the Induction of Stronger SIV-Specific CD8+ T Cell Responses1 , 2008, The Journal of Immunology.

[16]  V. Maino,et al.  IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. , 2006, The Journal of clinical investigation.

[17]  E. Gracely,et al.  Interleukin-15 Increases Effector Memory CD8+ T Cells and NK Cells in Simian Immunodeficiency Virus-Infected Macaques , 2005, Journal of Virology.

[18]  V. Bond,et al.  Characterization of Nef-CXCR4 Interactions Important for Apoptosis Induction , 2004, Journal of Virology.

[19]  V. Bond,et al.  Extracellular Nef Protein Targets CD4+ T Cells for Apoptosis by Interacting with CXCR4 Surface Receptors , 2004, Journal of Virology.

[20]  C. Sabin,et al.  Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. , 1996, AIDS.

[21]  R. Detels,et al.  Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. , 1993, Journal of acquired immune deficiency syndromes.

[22]  J. Pocidalo,et al.  The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value , 1992, Clinical and experimental immunology.

[23]  R. Johnstone,et al.  Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). , 1987, The Journal of biological chemistry.

[24]  Hakan Seckinelgin,et al.  The Institutionalization of Global AIDS and the Creation of the Joint United Nations Programme on HIV/AIDS (UNAIDS) , 2017 .

[25]  N. Bhardwaj,et al.  Plasmacytoid dendritic cells in HIV infection. , 2013, Advances in experimental medicine and biology.

[26]  V. Bond,et al.  HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions. , 2008, Ethnicity & disease.